ROMY J CABACUNGAN
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology TUCSON, AZ NPI 1417190828
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology AZ Amgen Inc. All categories
General Payments — all program years on this page
$26,622.94
- Category: General Payments
- Program years: PY2018–2024
- Record count: 1,378
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $5,408.28 across 165 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,882.47 | 159 |
| Travel and Lodging | $1,410.97 | 3 |
| Education | $114.84 | 3 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $2,759.76 | 47 |
| ABBVIE INC. | $686.74 | 32 |
| UCB, Inc. | $569.23 | 19 |
| Mallinckrodt Hospital Products Inc. | $231.37 | 8 |
| PFIZER INC. | $177.76 | 14 |
| Radius Health, Inc. | $155.01 | 7 |
| Organon LLC | $137.34 | 7 |
| GENZYME CORPORATION | $118.89 | 5 |
| Lilly USA, LLC | $92.59 | 4 |
| GlaxoSmithKline, LLC. | $72.58 | 4 |
| Octapharma USA, Inc. | $68.89 | 2 |
| ViiV Healthcare Company | $50.83 | 2 |
| Acerta Pharma LLC | $31.28 | 2 |
| Biogen, Inc. | $29.32 | 1 |
| Kyowa Kirin, Inc. | $28.17 | 1 |
| Alvogen Inc | $25.08 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.50 | 1 |
| Ferring Pharmaceuticals Inc. | $21.60 | 1 |
| TerSera Therapeutics LLC | $21.11 | 1 |
| Genentech USA, Inc. | $20.56 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.36 | 1 |
| SOBI, INC | $19.25 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.33 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.04 | 1 |
| Teva Pharmaceuticals USA, Inc. | $14.69 | 1 |
By program year
Records — PY2024 (165)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.